Ibutop (Ibuprofen)

Ibuprofen in Ibutop blocks the cyclooxygenase (COX‑1 and COX‑2) enzymes in peripheral tissues, which reduces the production of prostaglandins. Lower prostaglandin levels decrease inflammation and the sensitivity of pain receptors, providing local analgesic and anti‑inflammatory effects.

The appropriate amount of Ibutop is determined by the prescribing healthcare professional based on the individual’s condition, age, and response. Patients should follow the prescriber’s instructions and the product label for the correct amount and frequency of application.

Safety of topical ibuprofen during pregnancy or lactation has not been fully established. It should only be used if the prescriber deems the benefit outweighs potential risks. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To request Ibutop, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ibutop delivers ibuprofen directly to the skin, providing localized relief with lower systemic exposure compared with oral ibuprofen. This can reduce the risk of gastrointestinal and systemic side effects, but it is intended for surface pain and inflammation rather than widespread or severe pain that may require oral therapy.

Store Ibutop at room temperature, below 25 °C, in its original packaging. Keep it away from excessive moisture, direct sunlight and heat sources to maintain product stability and effectiveness.

Apply a thin layer of Ibutop to clean, dry skin over the painful or inflamed area. Gently rub it in until it disappears, usually no more than 3–4 times daily, or as directed by the prescriber. Do not cover the area with occlusive dressings unless advised.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, extensive dermatitis, and systemic NSAID effects like gastrointestinal bleeding, renal impairment, or liver dysfunction. Immediate medical attention is required if any signs of a serious reaction appear.

Individuals with known hypersensitivity to ibuprofen, other NSAIDs, or any component of the formulation should avoid Ibutop. It is also contraindicated in patients with active gastrointestinal ulcers, severe renal or hepatic disease, and those taking anticoagulants without medical supervision.